NeuroMetrix, Inc.

NeuroMetrix, Inc.

NeuroMetrix, Inc.

NeuroMetrix is a medical device company focused on the diagnosis and treatmentof the neurological complications of diabetes.
Type
B2c
Founded
1996
Raised
$71.8M
Follow us
Alexa global traffic share
Twitter followers
Latest funding Show all
$3,500,000
Post-IPO equity - 2017
$7,000,000
Post-IPO equity - 2017
Team Size
50+
Employees
ZDNet

NeuroMetrix CEO reflects on the art of AI in the art of healing

Robotics
$7,000,000 Post-IPO equity
businesswire

NeuroMetrix Closes $7.0 Million Private Placement of Preferred Stock and Warrants | Business Wire

$26,500,000 Post-IPO equity
MassDevice

NeuroMetrix raises $27m to buy back convertible shares, warrants

$21,000,000 Post-IPO equity
MassDevice

NeuroMetrix jumps on $21m round as Quell pain device hits 1k retail stores

$13,800,000 Post-IPO equity
BioPortfolio

NeuroMetrix Closes $13.8 Million At-The-Market Private Placement